100 related articles for article (PubMed ID: 18268888)
21. [Diversity of BCR and ABL gene breakpoints in chronic myelogenous leukemia].
Sugimoto T
Rinsho Ketsueki; 2003 Feb; 44(2):61-4. PubMed ID: 12692976
[No Abstract] [Full Text] [Related]
22. Quantitative monitoring of the T315I mutation in patients with chronic myeloid leukemia (CML).
Chomel JC; Sorel N; Bonnet ML; Bertrand A; Brizard F; Saulnier PJ; Roy L; Guilhot F; Turhan AG
Leuk Res; 2009 Apr; 33(4):551-5. PubMed ID: 18829107
[TBL] [Abstract][Full Text] [Related]
23. Younger age and shorter chronic phase in b2a2-positive chronic myeloid leukemia adults with high white blood cell count at diagnosis.
Martínez-Mancilla M; Gutiérrez M; de la Rosa GZ; García-Carrancá A; Gariglio P; Miranda E
Haematologica; 2002 Jun; 87(6):666-8. PubMed ID: 12031929
[No Abstract] [Full Text] [Related]
24. Chronic myelogenous leukemia, BCR-ABL1+.
Vardiman JW
Am J Clin Pathol; 2009 Aug; 132(2):250-60. PubMed ID: 19605820
[TBL] [Abstract][Full Text] [Related]
25. BCR-ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros.
Mullighan CG; Miller CB; Radtke I; Phillips LA; Dalton J; Ma J; White D; Hughes TP; Le Beau MM; Pui CH; Relling MV; Shurtleff SA; Downing JR
Nature; 2008 May; 453(7191):110-4. PubMed ID: 18408710
[TBL] [Abstract][Full Text] [Related]
26. No significance of derivative chromosome 9 deletion on the clearance kinetics of BCR/ABL fusion transcripts, cytogenetic or molecular response, loss of response, or treatment failure to imatinib mesylate therapy for chronic myeloid leukemia.
Kim DH; Popradi G; Sriharsha L; Kamel-Reid S; Chang H; Messner HA; Lipton JH
Cancer; 2008 Aug; 113(4):772-81. PubMed ID: 18543309
[TBL] [Abstract][Full Text] [Related]
27. Childhood CML in India: b2a2 transcript is more common than b3a2.
Hasan SK; Sazawal S; Kumar B; Chaubey R; Mishra P; Mir R; Chaudhry VP; Saxena R
Cancer Genet Cytogenet; 2006 Aug; 169(1):76-7. PubMed ID: 16875942
[No Abstract] [Full Text] [Related]
28. Technical aspects and clinical applications of measuring BCR-ABL1 transcripts number in chronic myeloid leukemia.
Foroni L; Gerrard G; Nna E; Khorashad JS; Stevens D; Swale B; Milojkovic D; Reid A; Goldman J; Marin D
Am J Hematol; 2009 Aug; 84(8):517-22. PubMed ID: 19544476
[TBL] [Abstract][Full Text] [Related]
29. Is p190 bcr-abl rearrangement necessary for acute transformation in some p210 CML of childhood?
Scrideli CA; de Oliveira FM; Brassesco MS; de Paula Queiroz R; Bernardes JE; Valera ET; Tone LG
Leuk Res; 2009 Mar; 33(3):495-9. PubMed ID: 18495245
[TBL] [Abstract][Full Text] [Related]
30. BCR-ABL, ETV6-RUNX1 and E2A-PBX1: prevalence of the most common acute lymphoblastic leukemia fusion genes in Mexican patients.
Jiménez-Morales S; Miranda-Peralta E; Saldaña-Alvarez Y; Perez-Vera P; Paredes-Aguilera R; Rivera-Luna R; Velázquez-Cruz R; Ramírez-Bello J; Carnevale A; Orozco L
Leuk Res; 2008 Oct; 32(10):1518-22. PubMed ID: 18455790
[TBL] [Abstract][Full Text] [Related]
31. Control genes in international standardization of real-time RT-PCR for BCR-ABL.
Moravcová J; Rulcová J; Poláková KM; Klamová H
Leuk Res; 2009 Apr; 33(4):582-4. PubMed ID: 18653236
[No Abstract] [Full Text] [Related]
32. Prospective monitoring of BCR-ABL1 transcript levels in patients with Philadelphia chromosome-positive acute lymphoblastic leukaemia undergoing imatinib-combined chemotherapy.
Yanada M; Sugiura I; Takeuchi J; Akiyama H; Maruta A; Ueda Y; Usui N; Yagasaki F; Yujiri T; Takeuchi M; Nishii K; Kimura Y; Miyawaki S; Narimatsu H; Miyazaki Y; Ohtake S; Jinnai I; Matsuo K; Naoe T; Ohno R;
Br J Haematol; 2008 Nov; 143(4):503-10. PubMed ID: 18986386
[TBL] [Abstract][Full Text] [Related]
33. Specific assessment of BCR-ABL transcript overexpression and imatinib resistance in chronic myeloid leukemia patients.
Bianchini M; De Brasi C; Gargallo P; Gonzalez M; Bengió R; Larripa I
Eur J Haematol; 2009 Apr; 82(4):292-300. PubMed ID: 19191867
[TBL] [Abstract][Full Text] [Related]
34. The proportion of different BCR-ABL1 transcript types in chronic myeloid leukemia. An international overview.
Baccarani M; Castagnetti F; Gugliotta G; Rosti G; Soverini S; Albeer A; Pfirrmann M;
Leukemia; 2019 May; 33(5):1173-1183. PubMed ID: 30675008
[TBL] [Abstract][Full Text] [Related]
35. [The genetic analysis of 180 cases of chronic myelogenous leukemia in Xinjiang area].
Liu H; Muerbaihe A; Guzailinuer W
Zhonghua Xue Ye Xue Za Zhi; 2013 Feb; 34(2):164-5. PubMed ID: 23611228
[No Abstract] [Full Text] [Related]
36. A case of chronic myelogenous leukemia with e8a2 fusion transcript.
Park IJ; Lim YA; Lee WG; Park JS; Kim HC; Lee HJ; Cho SR
Cancer Genet Cytogenet; 2008 Sep; 185(2):106-8. PubMed ID: 18722880
[TBL] [Abstract][Full Text] [Related]
37. Detection of BCR-ABL gene mutations in Philadelphia chromosome positive leukemia patients resistant to STI-571 cancer therapy.
Chien JH; Tang JL; Chen RL; Li CC; Lee CP
Leuk Res; 2008 Nov; 32(11):1724-34. PubMed ID: 18603297
[TBL] [Abstract][Full Text] [Related]
38. Performance of two commercially available BCR-ABL1 quantification assays that use an international reporting scale.
Seo SH; Lee SJ; Park S; Kim MJ; Song JY; Ra EK; Cho SI; Kim HK; Yang MG; Kim JY; Park SS; Seong MW
Clin Chem Lab Med; 2016 Jul; 54(7):1157-60. PubMed ID: 26587743
[TBL] [Abstract][Full Text] [Related]
39. Cytogenetic, fluorescence in situ hybridization, and molecular characterization of chronic myeloid leukemia in chronic phase with four BCR/ABL1 fusion signals: a case report.
Vargas MT; Portero MA; Rodríguez A; Reyes J; Fernández-Novoa C
Cancer Genet Cytogenet; 2009 Nov; 195(1):71-4. PubMed ID: 19837272
[TBL] [Abstract][Full Text] [Related]
40. In Ph+BCR-ABL1
Baccarani M; Iacobucci I; Chiaretti S; Foà' R; Balasubramanian P; Paietta E; Foroni L; Jeromin S; Izzo B; Spinelli O; Varma N; Menif S; Terragna C; Seth T; Bidet A; Coriu D; Lunghi F; Mayer J; Scappini B; Langabeer S; Maier J; Burt E; Candoni A; Albano F; Luppi M; Zupan I; Lion T; Zadro R; di Raimondo F; Poopak B; Rege-Cambrin G; Annunziata M; Ayala A; Salinas-Viedma V; Ines Prado A; Milner B; Galimberti S; Janssen J; Polli V; Comba L; Borsellino B; Annibali O; Crugnola M; Passamonti F
Leukemia; 2020 Mar; 34(3):929-931. PubMed ID: 31595038
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
